For the first time, Colin Farrell has opened up his home and talked in-depth about life with his son James, who has Angelman syndrome. James was just a toddler when he was diagnosed with the rare ...

Actor Colin Farrell recently disclosed that his son, James, has Angelman syndrome, one of the driving factors behind Farrell's support for finding a cure for Angelman syndrome and for launching the ...

Colin Farrell revealed that his 20-year-old son, James, has been living with a disorder known as Angelman Syndrome. While speaking with PEOPLE in a recent interview, the Saving Mr. Banks star, 48, ...

Colin Farrell says his personal life has inspired him to launch a new foundation aimed at helping people with intellectual disabilities. The actor, 48, recently launched the Colin Farrell Foundation, ...

It wasn’t long after our son Theodore was born that my husband, Daniel, and I noticed how incredibly happy he was. As in “Clap along if you feel like a room without a roof” kind of happy. He barely ...

Colin Farrell is opening up about life with his 20-year-old son who has Angelman syndrome. The Irish actor is sharing details of James’ life as they prepare for his 21st birthday, a milestone when ...

EASY TO MAKE FOR PEOPLE LIVING WITH DEMENTIA. WELL, TODAY WAS THE ANNUAL CHICAGO MARATHON AND EVERY YEAR, TENS OF THOUSANDS OF RUNNERS TAKE TO THE STREETS OF CHICAGO FOR 26.2 MILES. BUT ONLY A DOZEN ...

Actor Colin Farrell is known for being seen and heard on the big screen, but his next venture is about ensuring others, particularly those with intellectual disabilities, are treated with the same ...

3-year-old Bellamy Bresaw of Bow was diagnosed with Angelman Syndrome at nine months old. Credit: Delores Flanders / Courtesy Delores Flanders and her family are hosting a fundraiser at Boutwell’s ...

MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...

Positive End of Phase 2 discussion with FDA, including alignment on Phase 3 design Bayley-4 expressive communication selected as Phase 3 study primary endpoint Initiation of ION582 Phase 3 study ...